Max Healthcare Institute Limited (MAXHEALTH) — Corporate Action | 13 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Approved allotment of 3,048 ESOP shares
💡 Investor Takeaway
This small ESOP issuance slightly dilutes existing shareholders but has minimal financial impact.

On August 13, 2026, Max Healthcare Institute approved the allotment of 3,048 equity shares under its Employee Stock Option Scheme 2022, increasing paid-up capital to [amount not verified]. The shares were issued at a ₹350 exercise price with a ₹340 premium, resulting in a total issue value of [amount not verified]. This non-material ESOP issuance expands the share capital from 97.33 crore to 97.33 crore shares.

📄 View Original Announcement (PDF)

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹98,005.65 Cr P/E: 67.2 ROE: 13.6% ROCE: 14.4% Div Yield: 0.20%

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXHEALTH — Free

Free account · 2 AI queries/day